← Back
Data updated: Mar 10, 2026
ADAPT
OncologyInfectious DiseaseGastroenterology
ADAPT is a specialty pharmaceutical company focused on Oncology, Infectious Disease, Gastroenterology.
1971
Since
1
Drugs
-
Trials
3
Approved (2yr)
Key Drugs
No active drugs
Recent Activity
SEC Filings
Pro
Loading...
Therapeutic Focus
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Oncology 62%
0 drugs Phase 2: 3 Phase 1: 7
Infectious Disease 24%
0 drugs Phase 2: 1 Phase 1: 3
Gastroenterology 14%
0 drugs Phase 2: 1 Phase 1: 1
Pipeline Strength Pro
Loading...
Competitors Pro
Pfizer big-pharma
Oncology, Infectious Disease, Gastroenterology
Bristol-Myers Squibb big-pharma
Oncology, Gastroenterology, Infectious Disease
Gilead Sciences biotech
Infectious Disease, Oncology, Gastroenterology
WAYLIS THERAP big-pharma
Oncology, Infectious Disease, Gastroenterology
Merck big-pharma
Oncology, Infectious Disease
Active (1)
Discontinued (0)
Company Info
- First Approval
- 1971-04-13
- Latest
- 2002-10-25
- Applications
- 1